Cenerimod
Cenerimod (ACT-334441) is a potent and selective oral S1P1 receptor agonist with an EC50 of 1 nM. It is utilized in preclinical research to investigate autoimmune conditions, including studies in murine models of experimental autoimmune encephalomyelitis (EAE) and scleroderma.
Product Specifications
CAS Number
1262414-04-9
Product Name Alternative
Cenerimod, ACT334441, ACT-334441, ACT 334441, S1PReceptor, S1P Receptor, S1P1
Field of Research
Pharmacology & Drug Discovery
Purity
97.43% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.28 mM) ; DMSO:80 mg/mL (176.39 mM)
Smiles
CCc1cc (cc (C) c1OC[C@@H] (O) CO) -c1noc (n1) -c1cc (OC) nc (c1) C1CCCC1
Molecular Formula
C25H31N3O5
Molecular Weight
453.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1084946-01 0.02 mg (E-Coli)
Recombinant Coxiella burnetii Phosphate acyltransferase (plsX)
Sign In for Pricing
View Details MBS1084946-02 0.02 mg (Yeast)
Recombinant Coxiella burnetii Phosphate acyltransferase (plsX)
Sign In for Pricing
View Details MBS1084946-03 0.1 mg (E-Coli)
Recombinant Coxiella burnetii Phosphate acyltransferase (plsX)
Sign In for Pricing
View Details MBS1084946-04 0.1 mg (Yeast)
Recombinant Coxiella burnetii Phosphate acyltransferase (plsX)
Sign In for Pricing
View Details MBS1084946-05 0.02 mg (Baculovirus)
Recombinant Coxiella burnetii Phosphate acyltransferase (plsX)
Sign In for Pricing
View Details MBS1084946-06 0.02 mg (Mammalian-Cell)
Recombinant Coxiella burnetii Phosphate acyltransferase (plsX)
Sign In for Pricing
View Details